ClinicalTrials.Veeva

Menu

Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

K

Kyorin University

Status

Completed

Conditions

Epiretinal Membrane

Treatments

Procedure: Vitrectomy with internal limiting membrane removal

Study type

Observational

Funder types

Other

Identifiers

NCT02628158
Kyorineye019

Details and patient eligibility

About

Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.

Full description

92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.

Enrollment

91 patients

Sex

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The inclusion criteria were patients who underwent vitrectomy and internal limiting membrane removal for epiretinal membrane and had followed for more than 6 months.

Exclusion criteria

  • The patients with follow-up less than 6 months.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems